(Q33847189)

English

Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

8 references

22 March 2019

24 March 2019

22 April 2019

25 April 2019

17 June 2019

25 June 2019

25 July 2020

15 August 2020

neurological disorder

8 references

22 March 2019

24 March 2019

22 April 2019

25 April 2019

17 June 2019

25 June 2019

25 July 2020

15 August 2020

author name string

Alessandro Salviati

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Alessandro P Burlina

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Walter Borsini

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

19 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 June 2010

8 references

22 March 2019

24 March 2019

22 April 2019

25 April 2019

17 June 2019

25 June 2019

25 July 2020

15 August 2020

Neurological Sciences

9 references

Europe PubMed Central

PubMed publication ID

29 July 2017

22 March 2019

24 March 2019

22 April 2019

25 April 2019

17 June 2019

25 June 2019

25 July 2020

15 August 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

299-306

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Small fiber neuropathy in female patients with fabry disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Enzyme replacement therapy for Fabry disease: a systematic review of available evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Aseptic meningitis and ischaemic stroke in Fabry disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Evaluation of a low dose, after a standard therapeutic dose, of agalsidase beta during enzyme replacement therapy in patients with Fabry disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Diagnostic utility of different MRI and MR angiography measures in Fabry disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Home-based infusion therapy for patients with Fabry disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Home therapy for lysosomal storage disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy--a retrospective analysis from the Fabry Outcome Survey.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Neurological manifestations in Fabry's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Clinical results of enzyme replacement therapy in Fabry disease: a comprehensive review of literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Fabry disease: guidelines for the evaluation and management of multi-organ system involvement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Agalsidase alpha and hearing in Fabry disease: data from the Fabry Outcome Survey.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

CNS manifestations of Fabry's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Magnetic resonance imaging changes in Fabry disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Long-term safety and efficacy of enzyme replacement therapy for Fabry disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Cerebral vascular accidents in patients over the age of 60. II. Prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Carbamazepine in Fabry's disease: effective analgesia with dose-dependent exacerbation of autonomic dysfunction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

5 July 2018

Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy

1 reference

https://api.crossref.org/works/10.1007%2FS10072-009-0211-Y

21 January 2018

A case of Fabry disease with central nervous system (CNS) demyelinating lesions: a double trouble?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

29 October 2018

Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

29 October 2018

Enzyme replacement therapy with agalsidase alfa in a cohort of Italian patients with Anderson-Fabry disease: testing the effects with the Mainz Severity Score Index.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

29 October 2018

The pulvinar sign: frequency and clinical correlations in Fabry disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

29 October 2018

Neurology of Fabry disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

29 October 2018

Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

29 October 2018

Enzyme replacement therapy and intraepidermal innervation density in Fabry disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

29 October 2018

Home treatment for Fabry disease: practice guidelines based on 3 years experience in The Netherlands.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

29 October 2018

Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

29 October 2018

Auditory and vestibular findings in Fabry disease: a study of hemizygous males and heterozygous females.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

29 October 2018

Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

29 October 2018

Use of gabapentin to reduce chronic neuropathic pain in Fabry disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

29 October 2018

Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

29 October 2018

A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869001

29 October 2018

Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20300794

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzymatic Defect in Fabry's Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20300794

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The short-form McGill Pain Questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/20300794

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

White matter lesion severity in male and female patients with Fabry disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20300794

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis of Anderson-Fabry's disease in over seventy-year-old women: description of two cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/20300794

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Agalsidase-beta therapy for advanced Fabry disease: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20300794

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Neurological aspects of Fabry disease]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20300794

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic meningitis and lacunar stroke in Fabry disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20300794

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa

1 reference

https://pubmed.ncbi.nlm.nih.gov/20300794

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuropathic symptoms and findings in women with Fabry disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20300794

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/20300794

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10072-009-0211-Y

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33847189&oldid=2195872354"